Observational studyAnnals of surgical oncology2026

Adjuvant Immunotherapy Improves Esophageal Squamous Cell Carcinoma Survival After Neoadjuvant Chemoimmunotherapy: A Multicenter Real-World Study.

Zhuolun Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.